Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation

BACKGROUND: Human cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and giving valganciclovir when viral load exceeds a defined value. We hypothesised that such pre-emptive therapy should occur earlier than the standard 3000 genomes/ml (2520 IU/ml) when a seropositive donor t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lumley, Sheila, Green, Cameron, Rafferty, Hannah, Smith, Colette, Harber, Mark, O’Beirne, James, Jones, Gareth, Thorburn, Douglas, Marshall, Aileen, Shah, Tina, Zuhair, Mohamed, Rothwell, Emily, Atabani, Sowsan, Haque, Tanzina, Griffiths, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347177/
https://www.ncbi.nlm.nih.gov/pubmed/30682032
http://dx.doi.org/10.1371/journal.pone.0210420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347177/
https://www.ncbi.nlm.nih.gov/pubmed/30682032
http://dx.doi.org/10.1371/journal.pone.0210420

Ejemplares similares